New Merck Pill Cuts Bad Cholesterol by 60%, Potentially Replacing . . . Merck’s new pill, enlicitide, lowered LDL cholesterol by up to 60% in a new trial The pill works just as well as traditional PCSK9 injections but could cost less Researchers hope to receive federal approval in 2026 and launch the drug in 2027